Phil Mounteney, who is Dotmatics' vice president of science and technology, says the pandemic showed more relaxed regulations ...
Few Minnesotans sought COVID-19 vaccine to reduce their infection risks this winter, but at least the shots offered some protection for those who did. The current vaccine was 33% effective at ...
Trump's choice of RFK Jr. to be HHS secretary poses a risk to GOP lawmakers in the midterm elections if measles, bird flu, ...
Indiana's low measles vaccination rates among kindergarten students raises concerns as the first U.S. measles death in a decade is reported.
The Biden administration used a $900 million PR campaign to influence how Americans responded to the administration’s ...
Now that a confirmed case of measles has been identified in Kentucky, medical professionals share why the measles, mumps and rubella vaccine is an important part of keeping people healthy.
The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.
The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest ...
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results